Female | 265 (90.4) |
Age (years) | 46.87 (12.94) |
Time since diagnosis (years) | 9.12 (6.58) |
Smoking | 67 (22.9) |
Clinical activity | |
SLEDAI score | 2.77±2.83 |
SDI score | 1.00±1.25 |
Laboratory data | |
WBC (/µL) | 5709.86±2242.28 |
Lymphocyte (/µL) | 1629.91±757.93 |
Hemoglobin (/µL) | 13.89±6.61 |
Platelet (x1000 /µL) | 226.44±70.64 |
ESR (mm/h) | 19.24±15.50 |
hs-CRP (mg/dL) | 3.23±4.89 |
Hcy (µmol/L) | 12.44±7.25 |
Albumin (g/dL) | 4.08±0.37 |
AST (IU/L) | 23.71±10.80 |
ALT (IU/L) | 19.69±9.47 |
Complement C3 level (mg/dL) | 109.23±28.01 |
Complement C4 level (mg/dL) | 22.80±16.69 |
Medication used | |
Antimalarial use | 231 (79.4) |
Immunosuppressor use | 107 (36.8) |
Corticoid use | 114 (39.2) |
Clinical manifestations | |
Arthritis | 155 (55.6) |
Facial rash | 150 (53.8) |
Discoid lupus | 37 (13.3) |
Mucosal ulceration | 145 (52.0) |
Photosensitivity | 189 (67.7) |
Hemolytic anemia | 19 (6.8) |
Leukopenia | 168 (60.2) |
Thrombocytopenia | 41 (14.7) |
Neurological | 37 (13.3) |
Nephritis | 73 (26.2) |
Serositis | 36 (12.9) |